Loo uus konto

Registreeru ning avasta:
  • Personaalsed erihinnad
  • Tellimuse staatuse info
  • Eeltäidetud ja kiire tellimuse vormistamine
  • Tellimuste ajalugu ning mugav kordustellimine
  • Nähtav toodete laoseis
Cart

Sinu ostukorv on tühi, lisa mõni toode

Kui e-poes sobivat toodet ei leidu, siis meie tootejuhid on hea meelega valmis aitama, küsi julgelt!

Tarne

0,00 €

Kokku: 0,00 €

image/svg+xml Sisene / Registreeru
Sisene või registreeru
Logi sisse Loo konto
Registreeru ning avasta:
  • Personaalsed erihinnad
  • Tellimuse staatuse info
  • Eeltäidetud ja kiire tellimuse vormistamine
  • Tellimuste ajalugu ning mugav kordustellimine
  • Nähtav toodete laoseis
1-placeholder

Tootekood 004

APIS Breast Cancer Subtyping Kit (RUO*)
The APIS Breast Cancer Subtyping Kit is a highly reproducible, RT-qPCR-based kit for detecting mRNA expression of standard breast cancer biomarkers (HER2, ER, PR, Ki67) and novel proliferative biomarkers from core-needle biopsy (CNB) or resected formalin-fixed paraffin embedded (FFPE) breast tumour tissue. Receptor tyrosine-protein kinase erbB-2 (HER2), oestrogen receptor (ER), progesterone receptor (PR), and marker of proliferation (Ki67) biomarkers play a key role in breast cancer.
The kit also includes a novel four-gene proliferative signature that comprises four markers (MKI67, CCNA2, KIF23, and PCNA) associated with proliferation. These markers are expressed throughout all cell cycle stages, providing a more precise representation of tumour proliferation.
*APIS Breast Cancer Subtyping Kit is for Research Use Only (RUO), not for use in diagnostic procedures.

Features of the Assay
• Reliable and highly precise detection of HER2, ER, PR & Ki67 mRNA expression levels
• Reproducible and consistent results across multiple samples
• Novel four-gene proliferative signature provides a more precise representation of tumour proliferation
• Quick results in less than 5 hours when processing 10 samples

Specifications:
Kit size: 24 Samples in duplicate plus controls
Specimen requirements:

  • 10 µM FFPE core needle biopsy or resected tissue section
  • Neoplastic cells ≥20%

Turnaround time: Delivering precise results for standard biomarkers and a novel proliferative signature in less than 5 hours when processing 10 samples.

Additional information: https://www.biocartis.com/en/r...

Dokumendid

APIS-RUO-Leaflet.pdf

EN | 1,388 MB

Download

APIS-BCS-RUO-Technical-Sheet-Nov2023.pdf

EN | 920,585 KB

Download

Hiljuti vaadatud

Ettevõttest

Nova Natura UAB

Kaštonų g. 56, Giraitės k, LT-54310,
Kaunas, Lithuania

nova@novabio.lt
Phone: +370 (620) 70159

Reg No 305063819

Nova Natura OÜ

Valukoja 8, 11415,
Tallinn, Estonia

nova@novabio.ee
Phone: +37251939223

Reg No 14758203

NOVA uudiskiri

Liituge meie uudiskirjaga!
ISO9001 1 e1593687280362